|
Sudarshan Pharma Industries Ltd.
|
Nine Months RESULTS
|
|
|
You can view the
Nine Months Results
for the last 5 years.
|
Market Cap. (Rs.)
|
584.80 Cr.
|
P/BV
|
4.18
|
Book Value (Rs.)
|
5.82
|
|
52 Week High/Low (Rs.)
|
39/19
|
FV/ML
|
1/4000
|
P/E(X)
|
36.66
|
|
Bookclosure
|
23/11/2024
|
EPS (Rs.)
|
0.66
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 482.14 | 343.45 |
| Total Income From Operations | 482.14 | 343.45 |
| | | |
| EXPENDITURE | | |
| Consumption of Raw Materials | 18.94 | 4.04 |
| Purchase of Traded Goods | 459.52 | 324.29 |
| Increase/Decrease in Stocks | -49.13 | -27.26 |
| Employees Cost | 5.34 | 3.58 |
| Depreciation | 2.70 | 1.39 |
| Other Expenses | 16.35 | 14.81 |
| Total Expenses | 453.71 | 320.85 |
| | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 28.42 | 22.60 |
| Other Income | 4.59 | 1.68 |
| P/L Before Interest, Excpt. Items & Tax | 33.01 | 24.28 |
| Interest | 18.17 | 11.37 |
| P/L Before Exceptional Items & Tax | 14.84 | 12.91 |
| Exceptional Items | 0.00 | -1.17 |
| P/L Before Tax | 14.84 | 11.74 |
| Tax | 2.86 | 3.20 |
| P/L After Tax from Ordinary Activities | 11.98 | 8.54 |
| Net Profit/Loss For the Period | 11.98 | 8.54 |
| Net P/L After Minority Interest & Share Of Associates | 11.98 | 8.54 |
| | | |
| Equity Share Capital | 24.07 | 24.07 |
| EPS Before Extra Ordinary * | | |
| Basic EPS (Rs.) | 0.50 | 0.35 |
| Diluted EPS (Rs.) | 0.49 | 0.35 |
| EPS After Extra Ordinary * | | |
| Basic EPS (Rs.) | 0.50 | 0.35 |
| Diluted EPS (Rs.) | 0.49 | 0.35 |
| | | |
| PBITOE Margin (%) | 5.89 | 6.58 |
| PBTE Margin (%) | 3.07 | 3.75 |
| PBT Margin (%) | 3.07 | 3.41 |
| PAT Margin (%) | 2.48 | 2.48 |
| PAT After MI And SOA Margin (%) | 2.48 | 2.48 |
